Back to trial details

Intake questionnaire

A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1

Applying to Vanderbilt Vaccine (VV) CRS (Site ID: 30352) · Nashville, Tennessee

Answer a few short questions to share with the research team.

0 of 2 answered

1. Are you between 18 and 55 years old?
2. Are you able to travel to Nashville for study visits?